Immunoglobulins, Intravenous: all 232 studies that test it
Page 2 of 3. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic DiseaseCompletedNCT00288600Phase 4Results posted
- Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.CompletedNCT00278954Phase 3Results posted
- Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular DegenerationCompletedNCT00220805Phase 2Results posted
- Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple SclerosisCompletedNCT00220779Phase 2Results posted
- Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00220740Phase 3Results posted
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITPCompletedNCT00220727Phase 2Results posted
- Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
- Intravenous Immunoglobulin (IVIG) in Lung TransplantationCompletedNCT00115778Phase 2Results posted
- Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.CompletedNCT07532707Not applicable
- Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)Active, not recruitingNCT07193953Phase 1
- Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy ParticipantsCompletedNCT06753955Phase 1
- The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And EpigeneticsActive, not recruitingNCT06534450Phase 3
- RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)CompletedNCT06305793Phase 2
- Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLCWithdrawnNCT06064279Phase 1/2
- Early and Late Prognosis in Patients With Guillain-Barre SyndromeStatus unknownNCT06041451Phase 4
- Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for HypophosphatasiaWithdrawnNCT06015750Phase 4
- Add-on Intravenous Immunoglobulins in Early MyositisActive, not recruitingNCT05832034Phase 2/3
- Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived InfectionsStatus unknownNCT05799716Phase 4
- Therapies for Down Syndrome Regression DisorderCompletedNCT05662228Phase 2
- Phase III Clinical Study of NPB-01 in Patients With Autoimmune EncephalitisStatus unknownNCT05177939Phase 3
- BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)Active, not recruitingNCT05156710Phase 2
- Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn PatientsCompletedNCT05134792Phase 2/3
- IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome PatientsCompletedNCT05104762Phase 2/3
- Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)Active, not recruitingNCT04944979Phase 3
- Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)CompletedNCT04826588Phase 3
- Subcutaneous Immunoglobulin for Myasthenia GravisCompletedNCT04728425Phase 2
- Intravenous Immunoglobulin and Prednisolone for RPL After ART.CompletedNCT04701034Phase 2
- Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)CompletedNCT04643587Phase 1
- Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency DiseasesActive, not recruitingNCT04640142Phase 3
- IVIG in Patients With Severe COVID-19 Requiring Mechanical VentilationStatus unknownNCT04616001Phase 4
- Open-label Trial of IVIG in Children With PANSCompletedNCT04609761Phase 2
- Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical TrialStatus unknownNCT04548557Phase 3
- Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex TreatmentCompletedNCT04500067Phase 3
- Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)Active, not recruitingNCT04474223Phase 3
- Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)WithdrawnNCT04450654Phase 2
- Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)CompletedNCT04432324Phase 2
- NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILUREStatus unknownNCT04403269Phase 2
- rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)CompletedNCT04302805Phase 3
- The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected PneumoniaStatus unknownNCT04261426Phase 2/3
- Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.CompletedNCT04222023Phase 4
- A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)CompletedNCT04035135Phase 1
- IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific AntibodiesCompletedNCT04033276Phase 4
- Autologous Transplant To End NMO Spectrum DisorderWithdrawnNCT03829566Phase 2/3
- Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person SyndromeWithdrawnNCT03749096Phase 3
- Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory NeuropathiesCompletedNCT03700138Phase 3
- CPI Combination Therapy for Autoimmune EncephalitisCompletedNCT03542279Not applicable
- Intravenous Immunoglobulin for Unverricht-Lundborg Disease.Status unknownNCT03351569Phase 3
- A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)Status unknownNCT03348618Phase 4
- IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2Active, not recruitingNCT03194815Phase 2
- Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation FailureCompletedNCT03174964Phase 2
- Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy LossCompletedNCT03174951Phase 2
- Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility DiseaseStatus unknownNCT03130517Early Phase 1
- Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1CompletedNCT03018652Phase 2
- Single Dose Study of ANX005 in Healthy VolunteersTerminatedNCT03010046Phase 1
- Intravenous Immunoglobulin in Prevention of Preterm Neonatal SepsisCompletedNCT02954926Phase 3
- Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in ChildrenWithdrawnNCT02899702Phase 4
- Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316CompletedNCT02878616Phase 1
- Ig PRx in AECOPD: Pilot StudyCompletedNCT02690038Phase 2
- IVIg to Treat BK Viremia in Kidney Transplant RecipientsCompletedNCT02659891Phase 1
- Intravenous Immunoglobulin Therapy for Small Fiber NeuropathyCompletedNCT02637700Phase 2
- Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)CompletedNCT02556437Phase 2
- Immune Modulation Therapy for Pompe DiseaseStatus unknownNCT02525172Phase 4
- Study of Immunotherapy in Autoantibody Positive PsychosisCompletedNCT02449746Not applicable
- Different Doses of IVIG for Kawasaki DiseaseCompletedNCT02439996Phase 3
- Transcriptome Analysis of the Peripheral Blood in CIDPStatus unknownNCT02404298Not applicable
- A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse MyelitisTerminatedNCT02398994Phase 3
- IVIg for Demyelination in Diabetes MellitusStatus unknownNCT02372149Phase 4
- Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With EncephalitisCompletedNCT02308982Phase 3
- An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar AtaxiasStatus unknownNCT02287064Phase 1
- A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody DeficiencyCompletedNCT02247154Phase 4
- A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy VolunteersCompletedNCT02246855Phase 1
- Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré SyndromeCompletedNCT02221271Phase 3
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisActive, not recruitingNCT02205762Phase 2/3
- An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism SpectrumStatus unknownNCT02199925Phase 4
- Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled TrialCompletedNCT02111161Phase 2
- Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory ConditionsWithdrawnNCT02042027Phase 1
- Pharmacokinetics and Safety of IVIG Nanogam 100 mg/mlCompletedNCT01985373Phase 3
- LIME Study (LFB IVIg MMN Efficacy Study)CompletedNCT01951924Phase 3
- The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/SepsisTerminatedNCT01867645Phase 1
- Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.CompletedNCT01845584Phase 2
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.CompletedNCT01827072Phase 3
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
- IVIG Treatment in Systemic SclerosisStatus unknownNCT01785056Not applicable
- Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDASWithdrawnNCT01769027Phase 2
- Intravenous Gammaglobulin for Sickle Cell Pain CrisesCompletedNCT01757418Phase 1/2
- Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.CompletedNCT01696500Phase 3
- IVIG in Acute Ischemic Stroke: A Pilot StudyWithdrawnNCT01628055Phase 1
- Intravenous Immunoglobulins for Post-Polio SyndromeCompletedNCT01537575Phase 3
- Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney TransplantStatus unknownNCT01502267Phase 2
- Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)CompletedNCT01461018Phase 3
- Immune Globulin Subcutaenous (Human), 20%CompletedNCT01412385Phase 2/3
- Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to CorticosteroidsCompletedNCT01408550Phase 3
- Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary ImmunodeficiencyCompletedNCT01406470Phase 3
- Intravenous Immunoglobulins in Severe and Refractory Solar UrticariaCompletedNCT01360658Phase 2
- Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar AtaxiaCompletedNCT01350440Phase 2
- Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)CompletedNCT01306578Not applicable
- Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2/3
- Intravenous Immune Globulin (IVIG) to Prevent Neonatal InfectionCompletedNCT01203345Phase 2/3
- Intravenous Immunoglobulins in Complex-regional Pain SyndromeWithdrawnNCT00949065Phase 3
- Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated CardiomyopathyCompletedNCT00892112Phase 3